Printer-friendly versionPrinter-friendly version

Prevention of  viral hepatitis in Greece: Lessons learnt and the way forward

Athens, Greece,  November 15-16, 2007

Thursday, November 15, 2007

Session 1 Opening and objectives

Chair:  V Papaevangelou  - P Van Damme

09.00 - 09.30

  • Welcome and opening : J Pierroutsakos
  • Introduction of the participants
  • Introduction of the VHPB 366 Kb (.pdf)  P Van Damme
  • Introduction of KEEL (Hellenic Centre for Infectious Disease Control) 29 Kb (.pdf) A Zisouli
  • Objectives of the meeting:
    • Overview of surveillance systems for infectious diseases;
    • Update of the epidemiological situation on viral hepatitis;
    • Evaluation of current prevention and control measures on viral hepatitis;
    • Successes, problems and barriers to overcome, and the way forward
  • Review of the meeting programme
  • Pre-meeting document  333 Kb (.pdf)

Session 2 The health care system in Greece
Chair: E Manesis  - P Bonanni

09.30 - 09.50
Organisation of the health care system and financement in Greece 276 Kb (.pdf)
Y Tountas

09.50 - 10.10
National program for viral hepatitis prevention and control 247 Kb (.pdf)
J Pierroutsakos - A Zisouli

10.10 - 10.30
HBV immunization policies  199 Kb (.pdf)
A Konstantopoulos - V Papaevangelou

10.30 - 10.50
Coffee Break

Session 3 Surveillance systems in Greece
Chair: C Hadjichristodoulou - H Blystad

10.50 -11.10
Overview of HAV, HBV, and HCV surveillance 316 Kb (.pdf)
G Nikolopoulou

11.10 - 11.30
Experience gained from Surveillance of Infectious Diseases during the Olympics. How can we extend it to real life? 951 Kb (.pdf)
S Tsiodras

11.30 - 11.50
Vaccination uptake 189 Kb (.pdf)
T Panagiotopoulos

11.50 - 12.10
Migration and viral hepatitis 199 Kb (.pdf)
C Hadjichristodoulou – V Vasilopoulou

12.10 - 12.30
Surveillance in Blood Bank 234 Kb (.pdf)
A Varaklioti

12.30-14.15
Lunch

 

Session 4 Epidemiology of viral hepatitis in Greece
Chair: I Vafiadou  - W Jilg

14.15 - 14.40
Epidemiology of hepatitis B and D in Greece  348 Kb (.pdf)
G Papatheodoridis

14.40 - 15.00
Epidemiology of hepatitis C in Greece
M Raptopoulou-Gigi

15.00 - 15.30
Epidemiology of hepatitis A and E in Greece 274 Kb (.pdf)
V Papaevangelou

15.30 - 16.00
National Seroprevalence Study: Discussion of different approaches 229 Kb (.pdf)
G Touloumi

16.00 - 16.20
Discussion

16.20 – 16.45
EUVAC.NET’s activities: Expectations and Results 1.2 Mb (.pdf)
M Muscat

16.45
Close of the day

Friday, November 16, 2007

Session 5 Prevention and control of viral hepatitis in Greece
Chair: S Hadziyannis  - F Roudot-Thoraval

09.00 - 09.20 
Cohort of HBV and HCV patients 442 Kb (.pdf)
E Manesis

09.20 - 09.50 
Molecular epidemiology of HBV and HCV infection in Greece 2.9 Mb (.pdf)
D Paraskevis

09.50 - 10.20 
Viral hepatitis coinfection in HIV-infected patients 1.14 Mb (.pdf)
I Baraboutis

10.20 - 10.40 
Discussion and lessons learnt

10.40 - 11.00 
Coffee break

 
Session 6 Hepatitis A vaccination programmes
Chair:  S Badur – D Lavanchy

11.00 - 11.20 
The hepatitis A vaccination programme in Greece. Targeted versus Universal immunization  443 Kb (.pdf)
V Papaevangelou

11.20 – 11.40 
Hepatitis A universal vaccination: the Israel experience 310 Kb (.pdf)
D Shouval

11.40 – 12.00 
Discussions and lessons learnt

12.00 – 13.30 
Lunch

Session 7 Conclusions of the meeting
Chair:  D Shouval – S Wiersma

13.30 - 15.00 
Preliminary meeting conclusions  181 Kb (.pdf)
P Van Damme

15.00  Close of the meeting

Tags: